Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium

Anmoldeep Randhawa1,2, Nandita Pasari1,3, Tulika Sinha1

  • 1Microbial Engineering Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India.

Abstract

Insights

Penicillium funiculosum exhibits high drug tolerance, hindering genetic engineering. This study optimized transformation methods and developed CRISPR/Cas9 tools, enabling gene function analysis and improving this fungus for industrial applications.

Area of Science:

  • Mycology and Industrial Biotechnology
  • Genetic Engineering of Filamentous Fungi

Background:

  • Penicillium funiculosum NCIM1228 is a non-model fungus with industrial potential for lignocellulosic biomass saccharification.
  • Limited genetic engineering tools hinder its application due to high tolerance to common antibiotics.
  • Understanding and overcoming drug tolerance is crucial for developing reliable transformation methods.

Purpose of the Study:

  • To investigate the drug tolerance mechanisms in P. funiculosum.
  • To develop and optimize genetic engineering tools for P. funiculosum.
  • To establish a foundation for gene function analysis and strain improvement.

Main Methods:

  • Transcriptome analysis to identify efflux pump expression.
  • Optimization of antibiotic selection medium with efflux pump inhibitors.
  • Comparison of protoplast-mediated and Agrobacterium-mediated transformation.
  • Development of CRISPR/Cas9 gene editing system for P. funiculosum.

Main Results:

  • P. funiculosum shows high tolerance to hygromycin, zeocin, and nourseothricin.
  • Efflux pumps (ABC and MFS families) are highly expressed, contributing to drug tolerance.
  • Optimized selection medium and Ti-plasmid-based Agrobacterium-mediated transformation were effective.
  • Achieved 60% efficiency in homologous recombination-based gene deletions and developed a CRISPR/Cas9 system.
  • Deletion of Cellobiohydrolase I (CBH1) gene confirmed its essentiality for cellulolytic activity.

Conclusions:

  • Drug tolerability in P. funiculosum was addressed by optimizing selection conditions.
  • An efficient toolkit for genome modification, including CRISPR/Cas9, was developed.
  • This work enables future genetic studies and improvements of P. funiculosum for industrial use.